Mease, Philip http://orcid.org/0000-0002-6620-0457
Deodhar, Atul http://orcid.org/0000-0002-2130-1246
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (N/A)
Article History
Received: 10 November 2021
Accepted: 29 January 2022
First Online: 12 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: P. Mease has received research grants from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Janssen, Eli Lilly, Novartis, Pfizer, Sun Pharma, and UCB; consulting fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Galapagos, Gilead, Janssen, Eli Lilly, Novartis, Pfizer, Sun Pharma, and UCB; and speakers bureau fees from AbbVie, Amgen, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. A. Deodhar has received research grants from AbbVie, Eli Lilly, GSK, Novartis, Pfizer, and UCB and has received consulting fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Gilead, GSK, Janssen, Novartis, Pfizer, and UCB.